Intravitreal Triamcinolone Acetonide for Bilateral Acquired Parafoveal Telangiectasis

Archives of Ophthalmology

Volumn 121, Issue 11, 2003, Pages 1658-1659

  Martinez, Jose A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ACQUIRED PARAFOVEAL TELANGIECTASIS; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULA CYSTOID EDEMA; TREATMENT OUTCOME; VISUAL ACUITY;

FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; MALE; MIDDLE AGED; RETINAL DISEASES; RETINAL VESSELS; TELANGIECTASIS; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 0242610898     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.11.1658     Document Type: Article

References (2)

1. Gass JD. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. St Louis, Mo: Mosby Yearbook Inc; 1997:5, 7, 392-395.
2. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.